Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
BRIDGEWATER, N.J., April 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to seven new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
BRIDGEWATER, N.J., March 27, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will present nine abstracts from across its respiratory portfolio at the American Thoracic Society (ATS) 2024 International Conference, taking place May 17-22, 2024, in San Diego. Presentations will include late-breaking microbiologic data from the ARISE study of ARIKAYCE® (amikacin liposome inhalation suspension) in patients with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease who had not started antibiotics.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed wants to recognize patients who feel unseen or ignored, publishing a new survey, hosting a panel discussion with celebrity participants and debuting a new ad campaign.
Insmed To Present at Three March Conferences
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Result
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)